nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—Synthesis of PC—CHKB—narcolepsy	0.23	0.23	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—HRH3—narcolepsy	0.0729	0.0729	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Glycerophospholipid biosynthesis—CHKB—narcolepsy	0.0675	0.0675	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—CHKB—narcolepsy	0.0471	0.0471	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0406	0.0406	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.038	0.038	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0241	0.0241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0202	0.0202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0171	0.0171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0171	0.0171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—TNF—narcolepsy	0.0156	0.0156	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0152	0.0152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.0135	0.0135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.012	0.012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.0108	0.0108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.01	0.01	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00915	0.00915	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00911	0.00911	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00799	0.00799	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00695	0.00695	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00694	0.00694	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CHKB—narcolepsy	0.00676	0.00676	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00662	0.00662	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00662	0.00662	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00517	0.00517	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CPT1B—narcolepsy	0.00459	0.00459	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00392	0.00392	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00356	0.00356	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00326	0.00326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TRH—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPS—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000919	0.000919	CbGpPWpGaD
